Key result
Males with ischemic heart disease had a significantly higher frequency of abnormal oral glucose tolerance tests (37%) compared to age-matched healthy controls (19%).
Why the study?
Do carbohydrate and lipid metabolism responses during oral glucose tolerance tests differ between males with ischemic heart disease and healthy controls?
Case-Control (n=134)
Do carbohydrate and lipid metabolism responses during oral glucose tolerance tests differ between males with ischemic heart disease and healthy controls?
Absolute Event Rate: 37% vs 19%
Patients with ischemic heart disease exhibit a significantly higher prevalence of abnormal glucose tolerance and altered insulin and lipid metabolism compared to healthy individuals.
No takes yet. Share an insight, caveat, or question.
Abnormal glucose tolerance may be more prevalent in males with ischemic heart disease; this case-control finding is hypothesis-generating and requires prospective confirmation.
Gertler et al. (1972) conducted a case-control in Ischemic heart disease (n=134). Oral glucose tolerance tests (GTT) vs. Age-matched healthy controls was evaluated on Frequency of abnormal GTT. Males with ischemic heart disease had a significantly higher frequency of abnormal oral glucose tolerance tests (37%) compared to age-matched healthy controls (19%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: